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Comparing evidence-based psychotherapy (EBP) to usual care typically demonstrates the
superiority of EBPs, although this has not been studied for eating disorders EBPs such as
family-based treatment (FBT). The current study set out to examine weight outcomes for
adolescents with anorexia nervosa who received FBT through a randomized clinical
research trial (RCT, n = 54) or non-research specialty care (n = 56) at the same specialist
pediatric eating disorder service. Weight was recorded throughout outpatient treatment
(up to 18 sessions over 6 months), as well as at 6- and 12-month follow-up. Survival
curves were used to examine time to weight restoration [greater than 95% median body
mass index (mBMI)] as predicted by type of care (RCT vs. non-research specialty care),
baseline clinical and demographic characteristics, and their potential interaction. Results
did not indicate a signiﬁcant main effect for type of care, but there was a signiﬁcant effect
for baseline weight (p = .03), such that weight restoration was achieved faster across both
treatment types for those with a higher initial %mBMI. These data suggest that weight
restoration achieved in non-research specialty care FBT was largely similar to that
achieved in a controlled research trial.
Clinical Trial Registration: http://www.anzctr.org.au/, identiﬁer ACTRN12610000216011.
Keywords: anorexia nervosa, adolescents, eating disorder, family-based treatment, treatment outcomeINTRODUCTION
Anorexia nervosa (AN) is a particularly pernicious psychiatric illness with signiﬁcant morbidity and
mortality rates (1), considerable distress and impairment (2), and high treatment costs (3).
Implementing evidence-based psychotherapy (EBP) for adolescents with AN is a critical
endeavor as onset is most commonly in adolescence and early adulthood (4), and early
intervention typically yields the most favorable treatment outcomes (5). One potential stumbling
block in the implementation of EBPs in usual care is that, while the former outperforms the latter,g January 2020 | Volume 10 | Article 10011
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compared to the research settings in which they were developed
and tested (6). For example, strict inclusion criteria, together
with potentially different characteristics of patients and
families who are willing to participate in a research trial (and
subsequently be randomized to either arm of a study)
might limit the representativeness of clinical trial data. As such,
treatment outcomes from randomized clinical trials (RCTs)may not
generalize to individuals treated outside of these settings.
A recent meta-analysis summarizing the beneﬁt of
implementing EBPs over usual care showed that 58% of
randomly selected youth receiving EBPs would have better
outcomes than randomly selected youth receiving usual care
(effect size 0.29) (7). Notably, none of the 52 RCTs included in
this analysis were for eating disorders. Themost efﬁcacious EBP for
adolescentswithAN is family-based treatment (FBT), amanualized
intervention that emphasizes the role of parental support in
facilitating their child’s recovery from AN (8). An FBT approach
consists of an average of 6–12 months of therapeutic intervention;
the treatment includes three phases, whereby it is initially symptom
focused, with parents providing meal support and prevention of
compensatory behaviors with a primary goal of weight restoration.
FBT differs considerably from other approaches such as individual
therapy and inpatient management, in that parents are
instrumentally involved in their child’s weight restoration, and
resumption of appropriate eating and exercise behavior. Consistent
evidence suggests that FBT is an efﬁcacious therapy for this patient
population, contingent upon medical stability for outpatient
management (e.g., 9–11). However, research on provider attitudes
towards the use of EBPs for eating disorders suggests that there are
several barriers to using manualized treatments (12). Some argue
that evidence supporting EBPs is ﬂawed in important ways (13). In
particular, it is thought that manualized treatment formats may be
too rigid and not a “good ﬁt” for most patients seen in community
settings (14, 15). Therapists commonly endorse misconceptions
and negative beliefs about FBT prior to training (16). Further,
therapists who implement FBT often make signiﬁcant
modiﬁcations to treatment delivery (17), and in so doing, may
unintentionally compromise the effectiveness of treatment.
To date, only one study of adolescents receiving FBT for AN
compared the delivery of this treatment in a research trial (n =
32) versus usual care (n = 52) (18). These authors found that for
adolescents with a lower initial percent median body mass index
for age and height (%mBMI; 19), time to weight restoration was
signiﬁcantly faster in the research trial compared to usual care.
However, for those with a higher baseline %mBMI, time to
weight restoration was largely similar across care contexts. In this
sample, psychiatric comorbidity was greater in usual care than in
the RCT, suggesting that families of patients with elevated rates
of comorbidity may be less likely to participate in research trials.
In fact, Couturier and colleagues (12) have argued that a patient’s
clinical complexity may discourage community clinicians’ use of
FBT. Studies using highly controlled efﬁcacy designs, where all
providers involved in care are required to follow detailed
treatment protocols (e.g., RCTs), might be expected to produce
better outcomes compared with studies using effectivenessFrontiers in Psychiatry | www.frontiersin.org 2designs in which EBPs are evaluated under more usual practice
conditions. Therefore, evaluation of FBT with a more
representative sample in comparison to a research trial may be
particularly informative.
The current study aimed to build on the work by Accurso and
colleagues (18), who studied a private practice sample in the
United States, where cost differs signiﬁcantly between usual care
(insurance or self-pay cost) and randomized trial care (treatment
at no cost). Instead, the current study was conducted in a
geographically restricted public health care setting in Australia,
that is, the only specialist eating disorders service for this
particular region with no direct treatment costs to the families
receiving either treatment arm. Without cost barriers, it is
posited that patients managed within such a public health care
environment are perhaps more representative of the general
population of adolescents with AN.
The primary goal of this study was to investigate time to
weight restoration among patients who received FBT in the
context of an RCT versus non-research specialty care delivered
within an academic eating disorder service. While our study was
largely intended to generate hypotheses, we anticipated a
difference in time to weight restoration in favor of those
participating in the RCT. The secondary goal was to test the
potential moderating effect of baseline patient demographic and
clinical characteristics on outcomes, given that the public health
care setting of this study is likely to manage a more diverse
sample when compared to the prior US-based study conducted
in a private setting (18). Given the nascent evidence to date on
nuanced differences in adolescent treatment outcome relative to
moderators, secondary hypotheses remained exploratory.METHODS
Participants were 110 adolescents who met DSM-IV criteria for
AN, were medically stable, and were treated with conjoint FBT in
an outpatient setting, either through an RCT (RCT Care: n = 54)
or non-research specialty care (Non-Research Care: n = 56) from
2010 to 2016. Patients presented to the Royal Children’s Hospital,
a tertiary public hospital in Melbourne, Australia. The Human
Research Ethics Committee of the Royal Children’s Hospital
approved this study, and participants provided consent or assent
(RCT Care = written; Non-Research Care = written/waived)
prior to participation. All therapists had specialized training
and weekly supervision. Patients enrolled in the research study
experienced differences in treatment delivery compared to Non-
Research Care, including 1) sessions that were recorded, 2)
random assignment to conjoint FBT, or a separated format of
FBT, called parent-focused therapy (PFT), and 3) a requirement
to be on a stable course of medication for a minimum of 8 weeks,
or on no medication at all. The following reasons for exclusion
were noted: 3 = medication; 5 = too young; 1 = too young and
parents non-English-speaking; 3 = had FBT previously; 1 = had a
medical condition. Reasons for declining participation in the
study were as follows: 7 = no reason given; 5 = perceived burden
(e.g., time, effort, stress); 2 = did not want to commit to protocol.January 2020 | Volume 10 | Article 1001
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and Non-Research Care is detailed in Table 1.
Research Trial Care (RCT)
The RCT sample (n = 54) participants were aged between 12 and
18 years, met DSM-IV criteria for AN (excluding amenorrhea) or
Eating Disorder Not Otherwise Speciﬁed (AN type), were ≤ 90%
mBMI at baseline, lived with at least one parent who was available
to participate in treatment, and were evaluated for study
participation between July 2010 and July 2014. Exclusion criteria
were current psychotic disorder; drug or alcohol dependence;
acute suicidality; physical condition inﬂuencing eating or weight
(e.g., pregnancy); previous FBT; and psychotropic medication use
<8 weeks. Data on the number of participants who were screened
out for these reasons are reported in the main outcome paper (10).
Non-Research Care
The Non-Research Care sample (n = 56) was mixed [13 not eligible
for the RCT, 14 refused participation, and 29 not applicable (RCT
recruitment completed)], drawn from children and adolescents aged
8–18 who were evaluated in the same outpatient eating disorders
assessment clinic between August 2010 and November 2015, met
DSM-IV criteria for AN or Eating Disorder Not Otherwise Speciﬁed
(AN type), were ≤ 90%mBMI at baseline, and received FBT. The
same cohort of eight clinicians who provided care in the RCT were
available to provide care in this context. Therapists were doctoral-
and masters-level psychologists or certiﬁed family therapists.
Measures
Demographic and clinical characteristics were evaluated for all
participants during an eating disorders assessment clinic visit.
The same assessment battery was conducted at baseline, end-of-
treatment, and at 6- and 12-month follow-up for both groups.Frontiers in Psychiatry | www.frontiersin.org 3For the purposes of the current study, we only note the measures
of relevance to our primary research question (for the RCT
protocol, see 20).
Weight and height
Patient weights were taken at baseline, week 4, week 12, end-of-
treatment, and at 6- and 12-month follow-up; height was also
regularly measured. Depending on context and availability,
weights at weeks 4 and 12 were taken by 1) researcher (gown),
2) pediatrician/nurse (gown), or 3) therapist (lightly clothed).
Eating Disorder Examination
Eating Disorder Examination (EDE, 21). Diagnoses were
determined by EDE interview, and its global score was used to
determine baseline and subsequent eating disorder pathology.
The EDE has demonstrated good reliability and validity (see 22,
for review).
Child Depression Inventory
Child Depression Inventory (CDI; 23) is a 27-item self-report
measure of cognitive, affective, and behavioral symptoms of
depression in children and adolescents. Each item is scored on
a three-point scale (0–2) according to symptom severity. The
measure has demonstrated good reliability and validity (24).
Statistical Analyses
To explore the extent to which RCT Care was comparable to
Non-Research Care on baseline demographic and clinical
characteristics, independent t-tests, and chi-square tests were
used. Differences in treatment dose (i.e., total sessions, treatment
duration) between types of care were also examined with t-tests.
Survival analyses were used to compare the two samples on time
to achieve 95%mBMI (25, 26). Individuals who were not weightTABLE 1 | RCT Care vs. Non-research Specialty Care.
RCT Care Non-research Specialty Care
Setting Location Highly specialized eating disorder program located in a tertiary care
hospital
Medical/psychiatry care Provided by the team pediatrician and (if indicated) psychiatrist
Payment No-cost treatment
Wait list Brief (typically 2 weeks)
Contact and assessments Frequent contact and assessments throughout treatment and follow-up
with research staff
“Observation” Sessions audio taped (with consent) Sessions not recorded
Treatment Implementation Fixed dose (18 sessions) of manualized FBT with high adherence
required in implementation
Assignment Random assignment to FBT (versus parent-focused FBT) Clinical recommendation to
receive FBT
Therapists Degree Masters- and doctoral-level psychologists, or family therapy–trained
social workers
Training and
Supervision
Training/supervision Structured training and supervision in FBT provided on a weekly basis
with oversight of treatment adherence
Patients Referral route Clinical and personal referrals via a multi-disciplinary assessment clinic
Diagnosis AN with %mBMI ≤90
Age 12–18 years 8–18 years
Medication Other characteristics Stable dose of medication >8 weeks (or no medication) No differences No medication exclusion criteriaJanuary 2020 | Volume 10 | Article 1RCT, randomized controlled trial; FBT, family-based treatment; AN, anorexia nervosa; %mBMI, percent median body mass index; gray = similar; black = different.001
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“censored” observations, indicating that treatment response did
not occur prior to termination of the measurement period. A
Cox proportional hazard model was then ﬁtted using a log
logistic distribution. Chi-square tests were used to compare the
proportion of patients who had achieved 95%mBMI at 6- and
12-month follow-up, according to treatment group.
The following baseline variables were initially examined in
separate models (including main effects for the variable and type
of care, and their interaction) as predictors of time to weight
restoration: age, baseline %EBW, eating disorder pathology (i.e.,
EDE global score), duration of illness, psychiatric comorbidity,
hospitalization prior to treatment, psychotropic medication use,
depressive symptoms (i.e., CDI score), intact family status,
and parent education. Dichotomous predictors were coded as
−.5 and +.5, and continuous predictors were mean-centered (27).
Main effects and interactions that signiﬁcantly predicted time to
95% mBMI (p < .10) in their initial models were simultaneously
entered into a ﬁnal model. Factors speciﬁc to the therapist (e.g.,
personality, experience)werenotdetermined in thedataor included
in analyses. IBM SPSS Statistics 25 was used for all analyses.RESULTS
Missing Data
Partial to fully complete data were available for all participants
up to 6 months post-baseline. Weight data missing at week 4 was
only evident for those in Non-Research Care [n = 4 (3.6%)]; at
week 12, missing weight data were comparable for both groups
[n = 6 (5.5%) RCT and n = 7 (6.4%) Non-Research Care].
Compared to those with complete data, patients with incomplete
data were largely similar on eating disorder pathology,
psychiatric comorbidity, hospitalization prior to treatment,
psychotropic medication use, depression scores, intact family
status, or parent education. However, those with missing weight
data resulting from early treatment termination were older (15.6
vs. 14.7 years, t = −2.48 p = .02), had lower initial weights (79.3
vs. 84.3%mBMI, t = 4.19, p < .001), and has longer duration of
illness (10.1 vs. 7.5 months, t = −2.44, p = .02). Weight data were
available for all patients at their last treatment session (end-of-
treatment), for 69 patients at 6-month follow-up (RCT: n = 50,
89%; Non-Research Care: n = 19, 34%) and for 84 patients at 12-
month follow-up (RCT: n = 43, 79%; Non-Research Care: n =
41, 73%).
One participant had missing EDE data at baseline. While 36
(32.7%) were missing data on baseline parent education, these
data were missing at random, based on a non-signiﬁcant chi-
square statistic (c2 = .36, p = .84) for Little’s Missing Completely
at Random (MCAR) analysis (28). The CDI was not scored if
more than one item was missing, which resulted in 23
participants (21%) with missing baseline depressive symptom
data. Evaluation of all CDI items in the full sample and per
treatment group indicated these data were again missing at
random, based on a non-signiﬁcant chi-square statistic (c2 =
288.1, p = .81) for Little’s MCAR analysis.Frontiers in Psychiatry | www.frontiersin.org 4Participant Characteristics
Baseline participant characteristics are shown in Table 2. The
combined sample was primarily female (90.9%, n = 100) with a
mean age of 15.3 years (SD = 1.9). Mean %mBMI was 81.0 (SD =
6.3), with an average duration of illness of 12.3 months (SD =
9.5). There were no signiﬁcant differences between the two types
of care in psychiatric comorbidity.
Treatment Dose Across Type of Care
FBT was delivered in both arms over a course of 24 weeks (18
sessions); 15 patients (14%) (RCT = 7; Non-Research Care = 8)
had extended treatment [2–7 extra sessions (one outlier had 14
sessions); and 5–14 extra weeks (one outlier had 35 weeks)]. RCT
participants received a mean of 14.9 sessions [SD = 4.4; range: (4,
18)] over 19.5 weeks [SD = 6.7; range: (1.1, 26.1)]. Those in Non-
Research Care received a mean of 14.4 sessions [SD = 4.9; range:
(1, 18)] over 19.4 weeks [SD = 7.2; range: (0, 26.4)]. There were
no signiﬁcant between-group differences in treatment length or
dose (all ps > .50).
Time to Achieve Weight Restoration
Of the 110 participants, 37 (34%) were weight restored within 6
months of treatment (RCT: n = 19, 35%; Non-Research Care: n =
18, 32%). Across the full sample, the mean time to weight
restoration was 5 months (M = 21.12 weeks, SD = 3.86). Of
patients with weight data at 12-month follow-up (n = 84, 76%),
37 (44%) were weight restored (RCT: n = 19, 35%; Non-Research
Care: n = 18, 32%); there was no signiﬁcant between-group
difference in proportion of those weight restored, according to
treatment context (c2 = 0.001, p = .98).
In all initial models, the main effects for treatment context,
eating disorder pathology, illness duration, depression scores,
parent education, intact family status, psychiatric comorbidity,
psychiatric medication use, and hospitalization prior to
outpatient treatment were non-signiﬁcant (ps > .10). There
were signiﬁcant main effects for age (Wald chi-square = 5.19,
df = 1, p = .02, OR = 3.62, 95% CI = 1.19–10.94), such that those
who were younger were less likely to achieve weight restorationTABLE 2 | Sample Characteristics at Baseline.
RCT Care
(n = 54)
Non-Research Care
(n = 56)
p
Age (years), M (SD) 15.43 (1.33) 15.09 (2.25) .34
Male, n (%) 6 (11.1%) 4 (7.1%) .47
Australian born, n (%) 50 (92.6%) 54 (96.4%) .30
Intact family, n (%) 35 (64.8%) 37 (66.1%) .89
Parent education, M (SD) 9.56 (3.85) 8.89 (3.55) .45
AN binge/purge subtype, n (%) 14 (25.9%) 13 (23.2%) .74
Weight (%mBMI) 80.45 (5.41) 81.49 (7.08) .75
Global EDE Score, M (SD) 2.12 (1.75) 1.76 (1.54) .26
Duration of illness (months), M (SD) 11.07 (9.49) 13.50 (9.43) .18
Co-morbidity, n (%) 19 (35.2%) 16 (28.6%) .46
CDI Score, M (SD) 18.81 (10.87) 17.16 (9.23) .45
Psychotropic medication, n (%) 6 (11.1%) 8 (14.3%) .62
Hospitalization prior to FBT 21 (38.9%) 25 (44.6%) .54January 2020 | Volume 10 | Article 1Parent education = combined mean of years of education of both parents; %mBMI =
percent median body mass index for age and height; EDE, Eating Disorder Examination;
CDI, Child Depression Inventory.001
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also signiﬁcantly less likely to achieve weight restoration (Wald
chi-square = 7.11, df = 1, p = .01, OR = 0.66, 95% CI = 0.48–0.89).
There were no other signiﬁcant main effects or interactions
between variables of interest and treatment group (ps > .10).
The overallmodel includedmain effects for typeof care, age, and
%mBMI. There were 16 censored cases (RCT: n = 7, Non-Research
Care: n = 9) before the earliest event in the stratum, which were
dropped fromﬁnal analyses. The overallmodel did not signiﬁcantly
predict time to weight restoration (overall chi-square = 6.13, df = 3,
p= .11) (Figure 1). Themain effect of%mBMI (B= .07, SE= .03, p=
.03, OR= 1.07, 95%CI = 1.00–1.15) remained signiﬁcant, such that
weight restoration was achieved faster by those who had higher
baseline %mBMI. The main effects of age and treatment context
were not signiﬁcant (ps > .10).
DISCUSSION
The current study compared weight outcomes in a sample of
adolescents diagnosed with AN who received FBT via a research
trial or non-research specialty care, both treatments provided
within an academic specialist eating disorder service. Speciﬁcally,
this study investigated time to weight restoration across these
two groups, with a secondary aim to examine these trajectories
relative to potential baseline moderators. At baseline, there were
no between-group differences in any variables of interest (e.g., %
mBMI, eating disorder pathology). However, across both
treatment groups, those who were younger, or who had
entered treatment with a higher weight, were more likely to
achieve weight restoration within the 18 allotted sessions. Overall
ﬁndings from survival analyses indicated that the rate of weight
restoration did not appear to differ according to type of careFrontiers in Psychiatry | www.frontiersin.org 5(RCT vs. Non-Research Care) but that elevated baseline weight
remained a signiﬁcant predictor of achieving weight restoration
more quickly within treatment. These results are not surprising
given that patients who start treatment at a higher weight have
less weight to gain in order to achieve 95%mBMI.
Baseline demographic and clinical variables suggest that the
non-research specialty care sample of patients was quite similar to
the sample who participated in the RCT. Further, when provided
with the same treatment in the same clinic environment, the
current study provides preliminary evidence that the more strictly
implemented protocol of a trial did not appear to confer any
signiﬁcant advantage in achieving timely weight restoration, or
differences in sustained weight gain at 6- or 12-month follow-up.
Certainly, null ﬁndings can be difﬁcult to draw conclusions from
when sample sizes are modest or small, which is a potential
limitation of the current study. Increasing the generalizability of
research ﬁndings with comparable representativeness in study
samples is of critical importance. This study supports the notion
that FBT can be effective across a diverse patient population since
it was conducted in a public health care setting, which admits all
patients (geography as the only criterion for entry). However, the
highly controlled implementation of FBT across settings, which
typically only characterizes clinical trials, is difﬁcult to replicate in
true usual care settings. As a result, community providers may
signiﬁcantly modify EBP delivery (17), because of the constraints
on clinical practice outside specialty centers (e.g., lack of training,
supervision, support from a multidisciplinary team who further
convey to families, the value of FBT), whichmay ultimately impact
the likelihood of weight restoration at the end-of-treatment in
non-specialty settings (29). This study does not inform how setting
factors may inﬂuence implementation and outcomes in a usual,
community-based setting.FIGURE 1 | Time to weight restoration for randomized clinical trial (RCT) care vs. non-research specialty care.January 2020 | Volume 10 | Article 1001
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entered treatment with a lower %mBMI were the least successful
in achieving weight restoration by end-of-treatment. While this
may not seem surprising in the context of adolescents needing to
gain more weight, prior research found that time to achieve weight
restorationwas actually similar across%mBMIs, with the exception
that for patients at a lower %mBMI, signiﬁcantly fewer achieved
weight restoration in the context of non-research specialty care
compared to RCT care (18). Future work might further explore
individual differences that contribute to improved treatment
outcomes in order to maximize effectiveness of FBT for patients
who begin treatment at different baseline weights.
The US-based (18) and current Australia-based study were
conducted in academic settings with a history of undertaking
clinical trials. In these highly specialized settings, research can
examine whether differences in trial eligibility criteria (generally
stricter within a trial) are associated with different rates of remission.
As would be expected, clinicians who work in such settings are
accustomed to delivering protocol-driven care, presumably
comfortable with receiving supervision, and supportive of a
research environment, so treatment will look similar whether or
not a trial is underway. In the current study, approximately half of
the Non-Research Care group was treated after the RCT; the site
also had new clinicians starting in the midst of the combined time
period, rendering any speciﬁc differences that could be attributable
to clinician experience difﬁcult to track. While this is a study
limitation, it may also increase the overall generalizability of its
ﬁndings to real-world settings. A critical difference between the US-
based study (18) and our current study is that in a public health care
setting, the ability to pay typically will not affect any family or
provider decisions. In effect, we have demonstrated that within the
constraints of the current sample size, which arguably is modest,
and in consideration of the characteristics that were measured, there
were no signiﬁcant differences in eligibility or baseline
characteristics (e.g., psychiatric comorbidities), and that treatment
intensity appeared to be the same across the two treatment contexts.
However, one important question that remains unanswered is how
a “real-world” representative sample, receiving true usual care and
drawn from a setting outside the context where research trials areFrontiers in Psychiatry | www.frontiersin.org 6conducted, will compare to research-based care delivered in an
academic setting. Very little research has been done in this area.
Preliminary efforts to address this question appear promising (12,
18), but there is still relatively little implementation science in the
ﬁeld of eating disorders. Implementation efforts are needed to
further our understanding of treatment effectiveness in
community-based usual care settings and the factors that impact
implementation in order to maximize outcomes in these settings.DATA AVAILABILITY STATEMENT
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